Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950144-07-005944
Filing Date
2007-06-22
Accepted
2007-06-22 17:12:10
Documents
9

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS INC. g06286a1sv1za.htm S-1/A 2036790
2 EX-4.3 STOCK PURCHASE WARRANT, ISSUED TO S.C.O.U.T. HEALTHCARE FUND L.P. g06286a1exv4w3.htm EX-4.3 27788
3 EX-10.18 2007 LONG-TERM INCENTIVE COMPENSATION PLAN OF CUMBERLAND PHARMACEUTICAL g06286a1exv10w18.htm EX-10.18 99131
4 EX-10.19 2007 DIRECTORS' COMPENSATION PLAN OF CUMBERLAND PHARMACEUTICALS INC. g06286a1exv10w19.htm EX-10.19 55047
5 EX-23.1 CONSENT OF KPMG LLP g06286a1exv23w1.htm EX-23.1 2804
6 GRAPHIC g06286a1g0628602.gif GRAPHIC 3642
7 GRAPHIC g06286a1g0628603.gif GRAPHIC 4723
8 GRAPHIC g06286a1g0628611.gif GRAPHIC 8388
9 GRAPHIC g06286a1g0628610.gif GRAPHIC 337
  Complete submission text file 0000950144-07-005944.txt   2246924
Mailing Address
Business Address 209 TENTH AVENUE SOUTH SUITE 332 NASHVILLE, TN 37203
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-1/A | Act: 33 | File No.: 333-142535 | Film No.: 07937136
SIC: 2834 Pharmaceutical Preparations